Inhibins and activins: clinical advances in reproductive medicine (Q35064307)

6 August 2017

1 reference

title

Inhibins and activins: clinical advances in reproductive medicine (English)

1 reference

6 August 2017

Stephen Tong

1

0 references

Euan M. Wallace

object named as

Euan M Wallace

series ordinal

2

0 references

author name string

Henry G Burger

series ordinal

3

1 reference

6 August 2017

1 February 2003

1 reference

6 August 2017

Clinical Endocrinology

1 reference

6 August 2017

58

1 reference

6 August 2017

2

1 reference

6 August 2017

115-127

1 reference

Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.

6 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Signal transduction by the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

The inhibins and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Dimeric inhibin: a direct marker of ovarian aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

The site of inhibin production in ovarian neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Assessment of inhibin and p53 in granulosa cell tumors of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin-B: a likely candidate for the physiologically important form of inhibin in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Genetic, biochemical, and multimodal approaches to screening for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Feto-placental hypoxemia regulates the release of fetal activin A and prostaglandin E(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Physiological and regulatory roles of activin A in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Differential patterns of inhibin secretion in response to gonadotrophin stimulation in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin production by Sertoli cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Survival among U.S. women with invasive epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Immuno- and bioactive inhibin and inhibin alpha-subunit expression in rat Leydig cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Preeclampsia: an endothelial cell disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Activin betaA-subunit and activin receptors in human myometrium at term and during labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Activin is a nerve cell survival molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Follistatin-free activin A is not associated with preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Importance of FSH-releasing protein and inhibin in erythrodifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Serum inhibin and disease status in women with ovarian granulosa cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Serum levels of inhibin B in men with different causes of spermatogenic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Serum inhibins A and B fall differentially as FSH rises in perimenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Corticotropin-releasing hormone, corticotropin-releasing hormone–binding protein, and activin A in maternal serum: Prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Maternal serum inhibin A can predict pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Evaluation of serum inhibin A as a surveillance marker after conservative management of tubal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin A and pro-alpha C inhibin in Down syndrome and normal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Tribute to Patrick Steptoe: beginnings of laparoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

A prospective study of inhibin in granulosa cell tumors of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Adenocarcinomas of various sites may exhibit immunoreactivity with anti-inhibin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

The radioimmunoassay of bovine and human follicular fluid and serum inhibin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Activin A and inhibin A as possible endocrine markers for pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10 to 14 weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Inhibin forms in serum from postmenopausal women with ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Maternal serum total activin A and follistatin in pregnancy and parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Serum levels of inhibin in maternal and umbilical blood during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Changes in Molecular Weight Forms of Inhibin A and Pro- C in Maternal Serum during Human Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Sex cord-stromal tumors of the testis with entrapped germ cells: a lesion mimicking unclassified mixed germ cell sex cord-stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Dimeric Inhibins in Amniotic Fluid, Maternal Serum, and Fetal Serum in Human Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

Monoclonal antibody based ELISAs for measurement of activins in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01686.X

10.1046/J.1365-2265.2003.01686.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12580923